(VIANEWS) – First Solar (FSLR), Chart Industries (GTLS), Monmouth Real Estate Investment Corporation (MNR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. First Solar (FSLR)
36.8% sales growth and 18.11% return on equity
First Solar, Inc., a solar technology company, provides photovoltaic (PV) solar energy solutions in the United States, France, Japan, Chile, and internationally. The company manufactures and sells PV solar modules with a thin film semiconductor technology that provides a lower-carbon alternative to conventional crystalline silicon PV solar modules. It designs, manufactures, and sells cadmium telluride solar modules that converts sunlight into electricity. The company's residual business operations include project development activities, operations and maintenance services, and the sale of PV solar power systems to third-party customers. It serves developers and operators of systems, utilities, independent power producers, commercial and industrial companies, and other system owners. The company was formerly known as First Solar Holdings, Inc. and changed its name to First Solar, Inc. in 2006. First Solar, Inc. was founded in 1999 and is headquartered in Tempe, Arizona.
Earnings Per Share
As for profitability, First Solar has a trailing twelve months EPS of $11.21.
PE Ratio
First Solar has a trailing twelve months price to earnings ratio of 21.57. Meaning, the purchaser of the share is investing $21.57 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.11%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 27.2% and 51.1%, respectively.
Volume
Today’s last reported volume for First Solar is 2471850 which is 8.21% above its average volume of 2284240.
Yearly Top and Bottom Value
First Solar’s stock is valued at $241.81 at 16:22 EST, way below its 52-week high of $306.77 and way higher than its 52-week low of $129.22.
Moving Average
First Solar’s value is above its 50-day moving average of $221.44 and way higher than its 200-day moving average of $193.32.
2. Chart Industries (GTLS)
26.1% sales growth and 5% return on equity
Chart Industries, Inc. manufactures and sells engineered cryogenic equipment for the industrial gas and clean energy markets in the United States and internationally. The company operates in four segments: Cryo Tank Solutions, Heat Transfer Systems, Specialty Products, and Repair, Service & Leasing. It provides bulk and packaged gas cryogenic solutions for the storage, distribution, vaporization, and application of industrial gases; cryogenic trailers, ISO containers, bulk storage tanks, loading facilities, and regasification equipment for delivering liquefied natural gas (LNG) into virtual pipeline applications; and large vacuum insulated storage tanks as equipment for purchasers of standard liquefaction plants. The company also offers natural gas processing solutions; process technology, liquefaction capabilities, and critical equipment for the LNG, include small to mid-scale facilities, floating LNG applications, and large base-load export facilities; brazed aluminum heat exchangers, Core-in-Kettle heat exchangers, cold boxes, air cooled heat exchangers, pressure vessels, and pipe works; and air cooled heat exchangers and axial cooling fans for the HVAC, power, and refining applications. In addition, it provides highly engineered equipment that is used in specialty end-market applications for hydrogen, LNG, biofuels, CO2 Capture, food and beverage, aerospace, lasers, cannabis, and water treatment; and cryogenic components, include vacuum insulated pipes, specialty liquid nitrogen, end-use equipment, and cryogenic flow meters. Further, it provides extended warranties, plant start-up, parts, 24/7 support, monitoring and process optimization, repairing, maintenance, and upgrading services; plant services on equipment; and service locations that undertake installation, service, repair, maintenance, and refurbishment of cryogenic products, as well as equipment leasing solutions. Chart Industries, Inc. was founded in 1859 and is headquartered in Ball Ground, Georgia.
Earnings Per Share
As for profitability, Chart Industries has a trailing twelve months EPS of $2.24.
PE Ratio
Chart Industries has a trailing twelve months price to earnings ratio of 54.29. Meaning, the purchaser of the share is investing $54.29 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5%.
Yearly Top and Bottom Value
Chart Industries’s stock is valued at $121.60 at 16:22 EST, way below its 52-week high of $173.65 and way above its 52-week low of $101.60.
3. Monmouth Real Estate Investment Corporation (MNR)
21.7% sales growth and 28.66% return on equity
Mach Natural Resources LP, an independent upstream oil and gas company, focuses on the acquisition, development, and production of oil, natural gas, and natural gas liquids reserves in the Anadarko Basin region of Western Oklahoma, Southern Kansas, and the panhandle of Texas. The company was incorporated in 2023 and is headquartered in Oklahoma City, Oklahoma.
Earnings Per Share
As for profitability, Monmouth Real Estate Investment Corporation has a trailing twelve months EPS of $-0.21.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.66%.
Yearly Top and Bottom Value
Monmouth Real Estate Investment Corporation’s stock is valued at $16.54 at 16:22 EST, way under its 52-week high of $21.19 and way above its 52-week low of $14.40.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 21.6% and a negative 18.2%, respectively.
4. United Therapeutics Corporation (UTHR)
19.5% sales growth and 19.25% return on equity
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin, an infused formulation of the prostacyclin analogue treprostinil for subcutaneous and intravenous administration to diminish symptoms associated with exercise in pulmonary arterial hypertension (PAH) patients; Tyvaso, an inhaled formulation of treprostinil to enhance the exercise ability in PAH patients; Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Unituxin, a monoclonal antibody for treating high-risk neuroblastoma; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. The company also engages in developing OreniPro, RemoPro, Tyvaso DPI, Trevyent, Ralinepag, and Aurora-GT to treat PAH; Unexisome to treat bronchopulmonary dysplasia; and the research and development of various organ transplantation-related technologies, including regenerative medicine, xenotransplantation, and ex-vivo lung perfusion, as well as the development of medicine for other diseases. It has licensing and collaboration agreements with Medtronic, Inc. to develop and commercialize the implantable system for Remodulin; Caremark, L.L.C. to provide refills of implanted pumps at its infusion centers; DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of Remodulin; MannKind Corporation to develop and license treprostinil inhalation powder and Dreamboat devices; and Arena Pharmaceuticals, Inc. to develop ralinepag for the treatment of PAH. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.
Earnings Per Share
As for profitability, United Therapeutics Corporation has a trailing twelve months EPS of $21.77.
PE Ratio
United Therapeutics Corporation has a trailing twelve months price to earnings ratio of 16.19. Meaning, the purchaser of the share is investing $16.19 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.25%.
5. Workday (WDAY)
14.1% sales growth and 21.08% return on equity
Workday, Inc. provides enterprise cloud applications in the United States and internationally. Its applications help its customers to plan, execute, analyze, and extend to other applications and environments to manage their business and operations. The company offers a suite of financial management applications to maintain accounting information in the general ledger; manage financial processes, such as payables and receivables; identify real-time financial, operational, and management insights; enhance financial consolidation; reduce time-to-close; promote internal control and auditability; and achieve consistency across finance operations. It also provides spend management solutions that help organizations to streamline supplier selection and contracts, manage indirect spend, and build and execute sourcing events, such as requests for proposals; expense management solutions to submit and approve expenses; and a suite of human capital management applications that enables HR teams to hire, onboard, pay, develop, reskill, and provide employee experiences. In addition, the company offers planning applications; and applications for analytics and reporting comprising augmented analytics to surface insights to the line of business in simple-to-understand stories, machine learning to drive efficiency and automation, and benchmarks to compare performance against other companies. Further, it provides supply chain and inventory solutions to healthcare organizations; solutions to manage the end-to-end student and faculty lifecycle; and Workday Extend for customers and their developers to build custom applications. It serves professional and business services, financial services, healthcare, education, government, technology, media, retail, and hospitality industries. The company was formerly known as North Tahoe Power Tools, Inc. and changed its name to Workday, Inc. in July 2005. Workday, Inc. was incorporated in 2005 and is headquartered in Pleasanton, California.
Earnings Per Share
As for profitability, Workday has a trailing twelve months EPS of $5.21.
PE Ratio
Workday has a trailing twelve months price to earnings ratio of 50.61. Meaning, the purchaser of the share is investing $50.61 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.08%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 14.4% and 13.4%, respectively.
Sales Growth
Workday’s sales growth for the next quarter is 14.1%.
Yearly Top and Bottom Value
Workday’s stock is valued at $263.69 at 16:22 EST, way below its 52-week high of $311.28 and way higher than its 52-week low of $199.81.
Previous days news about Workday(WDAY)
- Workday to acquire evisort for improved AI prowess: stock to gain?. According to Zacks on Wednesday, 18 September, "This will enhance information accessibility and speed up the process of data extraction, enabling WDAY clients to transfer accurate financial or operational details to the Workday platform directly in a matter of seconds. "
6. Allstate (ALL)
12.7% sales growth and 17.84% return on equity
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments. The Allstate Protection segment offers private passenger auto and homeowners insurance; other personal lines products; and commercial lines products through agents, contact centers, and online. The Protection Services segment provides consumer product protection; protection and insurance products, including vehicle service contracts, guaranteed asset protection, road hazard tire and wheel, and paintless dent repair protection; and roadside assistance, device and mobile data collection services, and analytic solutions using automotive telematics information, as well as identity theft protection and remediation services. This segment also offers its products under various brands, including Allstate Protection Plans, Allstate Dealer Services, Allstate Roadside, Arity, Avail, and Allstate Identity Protection. The Allstate Health and Benefits segment provides life, accident, critical illness, short-term disability, and other health insurance products; stop-loss and fully insured group health products to employers; and short-term medical and medicare supplement insurance to individuals. The Run-off Property-Liability segment offers property and casualty insurance coverage that primarily relates to policies written during the 1960s through the mid-1980s. The Corporate and Other segment provides debt services, as well as non-insurance operations. It sells its products through agents, independent agents, call and contact centers, retailers, direct to consumer, wholesale partners, and affinity groups, as well as through online and mobile applications. The Allstate Corporation was founded in 1931 and is headquartered in Northbrook, Illinois.
Earnings Per Share
As for profitability, Allstate has a trailing twelve months EPS of $-1.19.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.84%.
Previous days news about Allstate(ALL)
- Why the market dipped but allstate (all) gained today. According to Zacks on Wednesday, 18 September, "The most recent trading session ended with Allstate (ALL Quick QuoteALL – Free Report) standing at $191.01, reflecting a +0.39% shift from the previouse trading day’s closing. ", "In terms of valuation, Allstate is currently trading at a Forward P/E ratio of 12.55. "
